journal article·2022-12Open access

Synergistic hydroxyl radical formation, system XC- inhibition and heat shock protein crosslinking tango in ferrotherapy: A prove-of-concept study of “sword and shield” theory

Li Xie, Wenjie Chen, Qifang Chen, Yang Jiang, Erqun Song, Xiaokang Zhu, Yang Song

Abstract

Ferroptosis provide new insights into designing nanomedicines for enhanced cancer therapy; however, its antitumor efficacy is relatively low, mainly due to self-protective mechanism of cancer cells, e.g., heat shock protein (HSP) overexpression. Since HSPs can be modified/inhibited by lipid peroxidation (LPO) ending products, we construct a nanoplatform, namely [email protected]3O4-Era, to amplify intracellular reactive oxygen species (ROS) and LPO for synergistic ferrotherapy. Upon tumor acidic microenvironment and local near-infrared stimuli, this nanoplatform releases Fe3O4 and reacts with intracellular hydrogen peroxide (H2O2) to promote Fenton reaction, and yields significant intracellular ROS (specifically hydroxyl radical, •OH) and LPO. In turn, LPO ending products crosslink HSPs to destroy self-preservation pathways of cancer cells to enhance anticancer effect. Meanwhile, the released erastin inhibits system XC− signal pathway to depletes glutathione. Fe3O4 loading further provides magnetic resonance imaging T2-weighted signal to guide anti-tumor treatment. Together, this nanoplatform not only provides •OH (as a “sword” to attack tumor cells), but also inhibits system XC− signal pathway and crosslinks HSP (break down the “shield” of tumor cells) to maximize synergistic ferro-therapeutic effect. [email protected]3O4-Era plus laser irradiation possessed highly efficient tumor suppression with magnified the levels of •OH and inactive glutathione peroxidase 4 (GPX4), which can promote the development of precise cooperative cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Redox biology and oxidative stress · Metal-Catalyzed Oxygenation Mechanisms · Free Radicals and Antioxidants

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. Ferroptosis and its modulation by autophagy in light of the pathogenesis of lysosomal storage diseases10.3390/cells10020365 ↗
2. Ferroptosis as a p53-mediated activity during tumour suppression10.1038/nature14344 ↗
3. Ferroptosis: the silver lining of cancer therapy10.3389/fcell.2021.765859 ↗
4. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics10.1021/acsnano.8b06399 ↗
5. Multifaceted mechanisms mediating cystine starvation-induced ferroptosis10.1038/s41467-021-25159-5 ↗
6. Regulation of ferroptotic cancer cell death by GPX410.1016/j.cell.2013.12.010 ↗
7. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis10.1073/pnas.1603244113 ↗
8. HSPA5 regulates ferroptotic cell death in cancer cells10.1158/0008-5472.CAN-16-1979 ↗
9. HSPB1 as a novel regulator of ferroptotic cancer cell death10.1038/onc.2015.32 ↗
10. Ferroptosis: mechanisms, biology and role in disease, Nature reviews
11. Autophagy promotes ferroptosis by degradation of ferritin10.1080/15548627.2016.1187366 ↗
12. Glutaminolysis and transferrin regulate ferroptosis10.1016/j.molcel.2015.06.011 ↗
13. Protein glycoengineering enabled by the versatile synthesis of aminooxy glycans and the genetically encoded aldehyde tag10.1021/ja206023e ↗
14. Coordinating the mechanism of actions of ferroptosis and photothermal effect for cancer theranostics10.1002/anie.202112925 ↗
15. Construction of a mesoporous polydopamine@GO/cellulose nanofibril composite hydrogel with an encapsulation structure for controllable drug release and toxicity shielding10.1021/acsami.0c15465 ↗
16. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe(3+) as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer
17. Novel tumor-microenvironment-based sequential catalytic therapy by Fe(II)-Engineered polydopamine nanoparticles10.1021/acsami.9b17951 ↗
18. Construction of a mesoporous polydopamine@GO/cellulose nanofibril composite hydrogel with an encapsulation structure for controllable drug release and toxicity shielding10.1021/acsami.0c15465 ↗
19. Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers10.1016/j.biomaterials.2020.120208 ↗
20. Core–satellite polydopamine–gadolinium-metallofullerene nanotheranostics for multimodal imaging guided combination cancer therapy10.1002/adma.201701013 ↗
21. Clearable black phosphorus nanoconjugate for targeted cancer phototheranostics10.1021/acsami.0c02718 ↗
22. Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response10.1021/nn4048974 ↗
23. Sequential intercellular delivery nanosystem for enhancing ROS-induced antitumor therapy10.1021/acs.nanolett.9b00336 ↗
24. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy10.1038/s41467-019-09566-3 ↗
25. Inhibition of mitochondrial ATP synthesis and regulation of oxidative stress based on {SbW8 O30 } determined by single-cell proteomics analysis10.1002/anie.202100297 ↗
26. Recent progress in ferroptosis inducers for cancer therapy10.1002/adma.201904197 ↗
27. Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells10.1016/j.redox.2013.08.006 ↗
28. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
29. Emerging mechanisms and disease relevance of ferroptosis10.1016/j.tcb.2020.02.009 ↗
30. Aptamer-dendrimer functionalized magnetic nano-octahedrons: theranostic drug/gene delivery platform for near-infrared/magnetic resonance imaging-guided magnetochemotherapy10.1021/acsnano.1c06667 ↗